News

Nestlé is launching a new food line next year meant to support Americans who use weight-management medications like Ozempic and Wegovy.. Vital Pursuit is the food company's first brand designed ...
Nestlé has announced plans to launch frozen foods that target weight-loss drug users.. In the last year, GLP-1 weight loss and diabetes drugs like Ozempic and Wegovy have skyrocketed in use as ...
Nestlé is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy. Roughly 1 in 8 adults in the U.S. has used ...
Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy. Watch NBC Bay Area News 📺 Streaming free 24/7 ...
Nestle is getting into the weight loss business. The world’s largest food and beverage company said it plans to launch a frozen food brand that will cater to consumers who use GLP-1 drugs such ...
Under its new Vital Pursuit brand, the global food giant plans to launch 12 products ranging from frozen protein pasta, sandwich melts and pizzas, all of which are made with a higher amount of ...
Nestle is getting into the weight loss business. The world’s largest food and beverage company said it plans to launch a ...
Nestlé has announced plans to launch frozen foods that target weight-loss drug users. In the last year, GLP-1 weight loss and diabetes drugs like Ozempic and Wegovy have skyrocketed in use as ...
Nestlé is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy.
Nestle plans to launch a frozen-food brand Vital Pursuit aimed at consumers who are taking Ozempic and Wegovy. GLP-1 drugs have taken off for weight loss and diabetes treatment, sparking investor ...
Nestlé has announced plans to launch frozen foods that target weight-loss drug users.. In the last year, GLP-1 weight loss and diabetes drugs like Ozempic and Wegovy have skyrocketed in use as ...